Preoperative Prehabilitation in Patients Planned for Liver Transplantation
PRELIVERT
Preoperative PREhabilitation in Patients Planned for LIVER Transplantation (PRELIVERT)
1 other identifier
interventional
60
1 country
1
Brief Summary
The objective of this study is to determine the feasibility and effectiveness of a home-based multimodal prehabilitation program in patients anticipated to be waitlisted for LT. Patients will participate in an eight week prehabilitation program consisting of physical exercise, nutritional support, smoking cessation and psychological counselling.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 2, 2024
CompletedFirst Submitted
Initial submission to the registry
November 25, 2024
CompletedFirst Posted
Study publicly available on registry
February 5, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
ExpectedFebruary 5, 2025
February 1, 2025
1.5 years
November 25, 2024
February 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Program satisfaction
Self-designed questionnaire score (score between 1-10, higher score means higher satisfaction)
At completion of the prehabilitation program (8 weeks after baseline/screening for LT)
Program compliance
Number of sessions that patient participates in the fitness training, the counselling on nutrition, smoking cessation and psychosocial sessions will be registered.
At completion of the prehabilitation program (8 weeks after baseline/screening for LT)
Percentage of patients willing to participate in the prehabilitation program
It will be registered which patients are willing and not willing to participate
At the outpatient clinic, when patients make their appointment for screening for LT
Secondary Outcomes (11)
Aerobic capacity
At start of the program, when patients are admitted for screening, they will perform a CPET as baseline. After eight weeks of home-based training the CPET will be reassessed.
Sarcopenia
At baseline (before start prehabilitation program) and after eight weeks.
Anthropometry
At baseline (before start prehabilitation program) and after eight weeks.
Functional capacity
At baseline (before start prehabilitation program) and after eight weeks.
Functional mobility
At baseline (before start prehabilitation program) and after eight weeks.
- +6 more secondary outcomes
Study Arms (1)
Home based prehabilitation
EXPERIMENTALParticipants will be subjected to a training period of eight weeks of a home-based multimodal prehabilitation program. The program consists of an exercise program, nutritional support, smoking cessation and psychological counselling.
Interventions
Participants will be subjected to an eight week home-based multimodal prehabilitaiton program. The program consists of an exercise program, nutritional support, smoking cessation and psychological counselling.
Eligibility Criteria
You may qualify if:
- Age ≥18 years,
- Anticipated waitlisting for LT,
- Speaks the Dutch language,
- Understands the purpose of the study and has given written informed consent.
You may not qualify if:
- Experienced a major adverse cardiovascular event in the past six months,
- Experienced a cerebrovascular incident in the past six months,
- Medical history of an uncontrolled heart rhythm disorder,
- Hepatic encephalopathy grade 3 or 4,
- Acute liver failure,
- Acute-on-chronic liver failure,
- Hospitalization at start of the study.
- Non-treated esophageal varices (i.e., no previous variceal eradication endoscopy or adequately dosed NSBB)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Erasmus Medical Centerlead
- Rijndam Revalidatiecentrumcollaborator
- Capri Hartrevalidatiecollaborator
Study Sites (1)
Erasmus Medical Center
Rotterdam, 3015 CN, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 25, 2024
First Posted
February 5, 2025
Study Start
October 2, 2024
Primary Completion
April 1, 2026
Study Completion (Estimated)
July 1, 2026
Last Updated
February 5, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share